Find the latest and updated news related to Fentanyl aggregated by PharmaCompass.com.

Fentanyl
News
Full Screen View

Fentanyl

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

25 Suppliers, 12 USDMF, 11 CEP/COS, 3 JDMF, 1 EU WC, 4 KDMF, 13 NDC API, 11 Listed Suppliers

DEVELOPMENTS

14 Drug(s) in Development

14 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports

INTERMEDIATES

5 Suppliers

5 Suppliers

DOSSIERs // Finished Dosage Forms

580 Dossiers, 71 FDA Orange Book, 369 Europe, 16 Canada, 75 Australia, 19 South Africa, 30 Listed Dossiers

DRUG PRODUCT COMPOSITION

FILM, EXTENDED RELEASE;TRANSDERMAL - 100MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FILM, EXTENDED RELEASE;TRANSDERMAL - 12.5MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FILM, EXTENDED RELEASE;TRANSDERMAL - 25MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FILM, EXTENDED RELEASE;TRANSDERMAL - 37.5MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FILM, EXTENDED RELEASE;TRANSDERMAL - 50MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FILM, EXTENDED RELEASE;TRANSDERMAL - 75MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 5 BASF, 3 DKSH, 2 Boai NKY Pharmaceuticals Ltd, 1 Actylis, 1 Huzhou Sunflower Pharmaceutical, 1 SPI Pharma, 1 Microlex e.U, 1 Alcedo Pharmachem

EXCIPIENTS BY APPLICATIONS

7 Topical, 7 Fillers, Diluents & Binders, 5 Direct Compression, 4 Film Formers & Plasticizers, 3 Thickeners and Stabilizers, 3 Rheology Modifiers, 2 Solubilizers, 2 Granulation, 1 Controlled & Modified Release, 1 Taste Masking, 1 Coating Systems & Additives

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 342 Finished Drug Prices

MARKET PLACE

4 APIs, 21 DOSSIERS // FDF

PATENTS

68 US Patents, 5 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 6 USP, 10 Others

DIGITAL CONTENT

9 Data Compilation & Company Tracker #PharmaFlow, 183 News

Nutriband Receives Trademark Allowance For AVERSA Abuse Deterrent Technology

POST ENQUIRY

Find the latest and updated news related to Fentanyl aggregated by PharmaCompass.com.

Fentanyl News Full Screen View

Fentanyl

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

25 Suppliers

12 USDMF

11 CEP/COS

3 JDMF

1 EU WC

4 KDMF

13 NDC API

11 Listed Suppliers

DEVELOPMENTS

14 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

INTERMEDIATES

5 Suppliers

DOSSIERs // Finished Dosage Forms

580 Dossiers

71 FDA Orange Book

369 Europe

16 Canada

75 Australia

19 South Africa

30 Listed Dossiers

DRUG PRODUCT COMPOSITION

FILM, EXTENDED RELEASE;TRANSDERMAL - 100MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FILM, EXTENDED RELEASE;TRANSDERMAL - 12.5MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FILM, EXTENDED RELEASE;TRANSDERMAL - 25MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FILM, EXTENDED RELEASE;TRANSDERMAL - 37.5MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FILM, EXTENDED RELEASE;TRANSDERMAL - 50MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FILM, EXTENDED RELEASE;TRANSDERMAL - 75MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

5 BASF

3 DKSH

2 Boai NKY Pharmaceuticals Ltd

1 Actylis

1 Huzhou Sunflower Pharmaceutical

1 SPI Pharma

1 Microlex e.U

1 Alcedo Pharmachem

EXCIPIENTS BY APPLICATIONS

7 Topical

7 Fillers, Diluents & Binders

5 Direct Compression

4 Film Formers & Plasticizers

3 Thickeners and Stabilizers

3 Rheology Modifiers

2 Solubilizers

2 Granulation

1 Controlled & Modified Release

1 Taste Masking

1 Coating Systems & Additives

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions

342 Finished Drug Prices

MARKET PLACE

4 APIs

21 DOSSIERS // FDF

PATENTS

68 US Patents

5 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM

6 USP

10 Others

DIGITAL CONTENT

9 Data Compilation & Company Tracker #PharmaFlow

183 News

Nutriband Receives Trademark Allowance For AVERSA Abuse Deterrent Technology

Braeburn Publishes Post Hoc Analysis of Phase 3 Study Data on BRIXADI

Nutriband Updates Development Of Aversa Fentanyl Lead Product

Cessation Therapeutics Presents Findings From Anti-Fentanyl Study

Fentanyl
News
Full Screen View

FILM, EXTENDED RELEASE;TRANSDERMAL - 100MCG/HR Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

FILM, EXTENDED RELEASE;TRANSDERMAL - 12.5MCG/HR Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

FILM, EXTENDED RELEASE;TRANSDERMAL - 25MCG/HR Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

FILM, EXTENDED RELEASE;TRANSDERMAL - 37.5MCG/HR Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

FILM, EXTENDED RELEASE;TRANSDERMAL - 50MCG/HR Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

FILM, EXTENDED RELEASE;TRANSDERMAL - 75MCG/HR Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons